期刊文献+

乐维棒营养替餐在超重和肥胖患者综合健康管理中的作用 被引量:3

Effect of Lifeway bar meal replacement on integrated health management in patients with overweight and obesity
下载PDF
导出
摘要 目的观察综合健康管理对超重和肥胖成人减重效果和对慢性代谢性疾病控制的影响及乐维棒替餐在管理中的作用。方法 160名超重和肥胖的成人随机平均分为乐维棒替餐组和对照组,均采用饮食运动心理结合的综合健康管理6个月,乐维棒替餐组每日使用一次乐维棒替餐。记录管理前后每个月高血压、糖尿病未达标人数、脂肪肝人数以及管理前及管理后2个月和6个月的体重指数、体脂百分数、腰臀脂肪比、甘油三酯、总胆固醇、高密度脂蛋白胆固醇指标的变化。结果两组高血压未达标率在第4个月时明显低于管理前,差异均有统计学意义(χ^2分别=5.78、7.11,P均〈0.05)。乐维棒替餐组的糖尿病未达标率第2个月时低于管理前,对照组糖尿病未达标率第4个月时低于管理前,差异均有统计学意义(χ^2分别=12.38、4.05,P均〈0.05)。乐维棒替餐组脂肪肝人数在第6个月时低于管理前,差异有统计学意义(χ^2=3.66,P〈0.05)。乐维棒替餐组的糖尿病未达标率与对照组比较下降更明显,两组间COX曲线差异有统计学意义(χ^2=4.35,P〈0.05)。两组管理前后体重指数、腰臀脂肪比、体脂百分数、甘油三酯、总胆固醇和高密度脂蛋白均明显好转,两组间比较差异无统计学意义(t分别=0.26、0.80、1.94、0.34、1.96、1.71,P均〉0.05)。乐维棒替餐组管理后2个月各项指标均较管理前明显好转,差异均有统计学意义(t分别=7.62、6.99、6.18、3.68、5.80、-6.39,P均〈0.05),管理后6个月与2个月比较差异也有统计学意义(t分别=8.69、14.24、10.75、4.30、7.45、-5.88,P均〈0.05)。对照组管理后2个月体重指数、腰臀脂肪比、甘油三酯、总胆固醇差异均有统计学意义(t分别=4.01、2.27、3.53、2.19,P均〈0.05),管理后6个月与2个月比较各项指标差异均有统计学意义(t分别=10.60、18.06、2.48、2.48、3.89、-3.71,P均〈0.05)。结论强化综合健康管理对超重和肥胖的成人减轻体重,控制代谢综合征均有明显的效果,加用乐维棒替餐能更快控制超重和肥胖病人中糖尿病病人的血糖水平。 Objective To observe the effects of integrated health management on losing weight of the overweight and obesity adults and controlling of chronic metabolic disease. Methods One hundred and sixty cases with overweight and obesity were randomly divided into lifeway group and control group. Both groups were received integrated health management with diet,exercise and psychology for 6 months. Lifeway group was received one lifeway bar meal replacement per day on the basis of conventional treatment. The numbers with hypertension and diabetes who did not reach the target and fatty livers were recorded before integrated health management and at every month after integrated health management.The body mass index(BMI),waist hip rate(WHR), body fat percentage, triglyceride, total cholesterol and high-density lipoprotein cholesterol(HDL-C)were assessed 2 and 6 month after integrated health management were also recorded and compared. Results The numbers of hypertension who did not reach the target in both groups were significantly decreased at 4 months after integrated health management(χ2=5.78, 7.11, P〈0.05). The numbers of diabetes who did not reach the target in lifeway group and control group were significantly decreased at 2 months and 4 months after health management respectively(χ^2=12.38, 4.05, P〈0.05). In lifeway group, the numbers of fatty liver were significantly decreased at 6 months after health management(χ^2=3.66,P〈0.05). With integrated health management, the numbers of diabetes who did not reach the target and the numbers of fatty liver in lifeway groups were gradually decreased.The difference were statistically significant when compared with control group(χ^2=4.35, P〈0.05). The levels of BMI,WHR, body fat percentage, triglyceride, total cholesterol and HDL-C in both groups were significant improved after the health man agement. There were no significant difference between the two groups(t =0.26,0.80,1.94,0.34,1.96,1.71,P〉0.05). In lifeway group, there were significant difference in BMI, WHR, body fat percentage, triglyceride,total cholesterol and HDL-C between 2 months after health management and before management(t=7.62, 6.99, 6.18, 3.68,5.80,-6.39, P〈0.05) as well as compared with 6 months after health management(t=8.69, 14.24, 10.75, 4.30, 7.45,-5.88,P〈0.05). In control group, there were significant difference in BMI, WHR, triglyceride and total cholesterol between 2months after health management and before management(t=4.01, 2.27, 3.53, 2.19, P〈0.05). The BMI,WHR, body fat percentage, triglyceride, total cholesterol and HDL-C between 2 months and 6 months after health management were significantly different(t =10.60,18.06,2.48,2.48,3.89,-3.71,P〈0.05). Conclusion Integrated health management has obvious effect on losing weight and controlling of the metabolic syndrome in patients with overweight and obesity. Lifeway bar meal replacement is more efficacious in controlling blood glucose level in diabetic patients.
出处 《全科医学临床与教育》 2016年第4期369-373,共5页 Clinical Education of General Practice
基金 浙江省教育厅科研项目(Y201330223)
关键词 乐维棒营养替餐 超重 肥胖 健康管理 lifeway bar meal replacement overweight obesity health management
  • 相关文献

参考文献13

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2011年版)[S].中国糖尿病杂志,2012,20(1):S1-S37.
  • 2中国高血压防治指南修订委员会.中国2型糖尿病防治指南2010年版[S].中华高血压杂志,2011,19(8):701-743.
  • 3Gortmaker SL,Swinbum BA, Levy D, et al. Changing the future of obesity:science,policy and actio[J]. Lancet, 2011, 378(9793) : 838-847.
  • 4中国成人肥胖症防治专家共识[J].中华内分泌代谢杂志,2011,27(9):711-717. 被引量:561
  • 5Robert AK, Likrissa,Jessica H, et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice[J]. PLoS Genetics, 2006, 1(5): e81.
  • 6Moran IJ, Luscombe-Marsh ND, Noakes M, et al. The satiating effect of dietary protein is unrelated to postprandial ghrelin secretion[J]. Clin Endocrinol Metab, 2005,90(9): 5205.
  • 7Araya H, Hills J, Alvina M, et al. Short-term satiety in preschool children: a comparison between high protein meal and a high complex carbohydrate meal[J]. Food Sci Nutr, 2000,51(2): 119-124.
  • 8Due A,Toubro S, Skov AR,et al. Effect of normal-fat diets, either medium or high in protein, on body weight in overweight subjects: a randomized 1-year trial [J]. Obes Relat Metab Disord, 2004,28(10) : 1283-1290.
  • 9Bluher M, Bullen JW Jr, Lee JH, et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle:associations with metabolic parameters and insulin resistance and regulation by physical training [J]. Endocrinol Metab, 2006,91 (6) : 2310-2316.
  • 10程璐,万晓晨,范芳华,李萌,周欢琴,于小妹.超重肥胖与正常体重人群的促生长激素释放激素、胰高血糖素样肽1、瘦素、脂联素的研究[J].全科医学临床与教育,2013,11(5):552-554. 被引量:5

二级参考文献29

  • 1武阳丰,马冠生,胡永华,李艳平,李贤,崔朝辉,陈春明,孔灵芝.中国居民的超重和肥胖流行现状[J].中华预防医学杂志,2005,39(5):316-320. 被引量:567
  • 2谢宗林,陈卫玲.中青年男性体重指数与血压、血脂、血糖关系的分析[J].现代预防医学,2006,33(6):903-904. 被引量:27
  • 3唐兰,屈小英,张明军,谢薇波,马贵成.体重指数及血脂甘油三酯与脂肪肝的相关性分析[J].重庆医科大学学报,2007,32(4):410-412. 被引量:17
  • 4周永昌,郭万学.超声医学[M].第3版,北京:北京科学技术出版社.1997.793.
  • 5中国肥胖问题工作组.中国成人超重和肥胖症预防控制指南(试行)2003版.
  • 6Bao Y,Lu J,Wang C,et al.Optimal waist circumference cutoffs for abdominal obesity in Chinese.Atherosclerosis,2008,201:378-384.
  • 7Dong X,Liu Y,YangJ,et al.Efficiency of anthropometric indicators of obesity for identifying cardiovascular risk factors in a Chinese population.Postgrad Med J,2011,87:251-256.
  • 8Xu F,Wang YF,Lu L,et al.Comparison of anthropometric indices of obesity in predicting subsequent risk of hyperglycemia among Chinese men and women in China's Mainland.Asia Pac J Clin Nutr,2010,19:586-593.
  • 9Shi XD,He SM,Tao YC,et al.Prevalence of obesity and associated risk factors in Northeastern China.Diabetes Res Clin Pract,2011,91:389-394.
  • 10Tsigosa C,Hainer V,Basdevant A,et al.Management of obesity in adults:European clinical practice guidelines.Obes Facts,2008,1:106-116.

共引文献564

同被引文献22

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部